Vetter is building a high-performance filling line for syringes at its Ravensburg Vetter South location. The new line can handle batches of as much as 1 million units per day and is well suited for the aseptic filling of high-volume products, like vaccines, according to the company.

The company is also expanding its services for the early clinical phases of new drugs. At its Vetter Development Service locations in Chicago and Ravensburg, the company offers a range of services including formulation support and customized packaging development. With another new filling line at the Ravensburg facility and further investments planned in Chicago, Vetter continues to increase its capabilities in clinical manufacturing.

“Vetter is continuously and strategically investing in its partnerships with international customers,” said Peter Soelkner, Vetter Managing Director. “In the area of prefilled syringes, we provide our partners a full range of service, from small batches manufacturing and support in early clinical stages to high-volume manufacturing for large scale commercial production.”